Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05974644 · ClinicalTrials.gov registry record
Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry
A clinical trial, sponsored by Virginia Commonwealth University.
- Not yet
- Registry status
- 1,000
- Enrollment target
NCT05974644: Clinical Trial study, sponsored by Virginia Commonwealth University.
NCT05974644 is a clinical trial that has not yet begun recruiting, run by Virginia Commonwealth University. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05974644 has not yet begun recruiting, sponsored by Virginia Commonwealth University.
- NOT YET RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The study design is a prospective registry including asymptomatic and symptomatic patients who carry a pathogenic TTR mutation. The study will enroll patients who meet the inclusion criteria and none of the exclusion criteria until 1000 patients are enrolled, at which point in time the study investigators will evaluate whether further patient accrual is meaningful.
Primary Outcome
For those enrolled as asymptomatic carriers, it will be assessed if they develop cardiac or extra cardiac amyloidosis
Interventions
- OTHER Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-07 |
| Est. Completion | 2030-12-01 |
What is known before NCT05974644 opens enrollment
NCT05974644 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Registry is the first listed.
NCT05974644 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05974644 about?
NCT05974644 is a clinical study titled "Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry". The study design is a prospective registry including asymptomatic and symptomatic patients who carry a pathogenic TTR mutation. The study will enroll patients who meet the inclusion criteria and none of the exclusion criteria until 1000 patients are enrolled, at which point in time the study investi...
What is the current status of trial NCT05974644?
This trial is currently not yet recruiting. The enrollment target is 1,000 participants. The study started on 2026-07. Estimated completion is 2030-12-01.
What interventions are being tested in trial NCT05974644?
The interventions under investigation include: Registry (OTHER).
Who is sponsoring clinical trial NCT05974644?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia